NEW YORK, March 13, 2018 /PRNewswire-USNewswire/
-- New research appears to confirm the association between
fluoroquinolone antibiotics and acute aortic injuries.
The study, which was published this month in BMJ, drew data from
Swedish health registries, with its authors identifying cases
of aortic aneurysm or dissection that had occurred in the
country from July 2006 to
December 2013. A total of 360,000
cases in which the patients had been using fluoroquinolone
antibiotics were compared to an equal number of cases where
patients had been taking amoxicillin.
The analysis suggested that the use of Cipro, Avelox or Levaquin
increased the risk for aortic injury by 66%, with 1.2 cases of
aortic aneurysm or dissection occurring for every 1,000-person
years in the fluoroquinolone group, compared to 0.7 cases among
those taking amoxicillin. When the authors of the report looked at
aortic aneurysm alone, the risk nearly doubled.
"Our firm is representing numerous individuals who were
allegedly harmed by Levaquin, Cipro or Avelox, including several
who suffered aortic aneurysm or aortic dissection. This study
provides further evidence to support their claims," says Sandy A.
Liebhard LLP, a partner at Bernstein Liebhard LLP, a nationwide law
firm representing victims of defective drugs and medical devices.
The Firm is offering free, no-obligation legal reviews to
individuals who were diagnosed with aortic injuries or peripheral
neuropathy allegedly related to treatment with Levaquin, Cipro or
Avelox.
Fluoroquinolone Side Effects
Levaquin, Cipro, and Avelox are used to treat a wide range of
bacterial infections, including staph, pneumonia, urinary tract
infections, E. coli and salmonella. While they are widely used,
antibiotics in this class have been tied to a number of significant
risks, including peripheral neuropathy and acute aortic
injuries.
While the possibility of peripheral neuropathy was first noted
on the drugs' labeling in 2004, the U.S. Food & Drug
Administration (FDA) ordered fluoroquinolone manufacturers to
updated their product labels in 2013 to better reflect the rapid
onset of peripheral neuropathy symptoms, as well as the potential
for permanent nerve damage
In May 2016, the FDA advised
restricting the use of systemic fluoroquinolone antibiotics for
certain uncomplicated infections, including acute sinusitis, acute
bronchitis, and uncomplicated urinary tract infections, when other
treatment options are available. The advisory was issued after an
agency review concluded that fluoroquinolones were associated with
severe and potentially permanent side effects involving the
tendons, muscles, joints, nerves, and central nervous system.
Individuals who were diagnosed with peripheral neuropathy or
aortic injuries following treatment with Levaquin, Cipro or Avelox
may be entitled to compensation for their medical bills, lost wages
and other damages related to their injuries. To learn more,
please visit Bernstein Liebhard LLP's website. Free, no-obligation
legal consultations can also be obtained by calling
800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm
exclusively representing injured persons in complex individual and
class action lawsuits nationwide since 1993. As a national law
firm, Bernstein Liebhard LLP possesses all of the legal and
financial resources required to successfully challenge billion
dollar pharmaceutical and medical device companies. As a result,
our attorneys and legal staff have been able to recover more
than $3.5 billion on behalf of our clients. Bernstein
Liebhard LLP is honored to once again be named to The National Law
Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs
firms in the country. This year's nomination marks the thirteenth
year the firm has been named to this prestigious annual list.
Bernstein Liebhard LLP
10 East 40th Street
New York, New
York 10016
800-511-5092
ATTORNEY ADVERTISING. © 2018 Bernstein Liebhard LLP. The law
firm responsible for this advertisement is Bernstein Liebhard LLP,
10 East 40th Street, New York, New York 10016,
800-511-5092. Prior results do not guarantee or predict a similar
outcome with respect to any future matter.
Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com
http://www.rxinjuryhelp.com/
https://plus.google.com/115936073311125306742?rel=author
View original content with
multimedia:http://www.prnewswire.com/news-releases/new-research-appears-to-confirm-increased-risk-of-aortic-aneurysm-aortic-dissection-from-levaquin-and-other-fluoroquinolone-antibiotics-bernstein-liebhard-llp-reports-300613282.html
SOURCE Bernstein Liebhard LLP